Ensure open access to genetic data to protect innovation

The following is an excerpt. Find a link to the full story below.

Public investment in the Human Genome Project was expected to deliver a global public good that would help generate scientific breakthroughs. But open access to our genetic blueprint is a precondition to achieving this and gene patenting – where companies have monopoly rights over genetic material – threatens to undermine it.

Allowing patents that capture categories of unique genomic DNA damages the principle of open access. A related constraint – and one that can impact research and diagnostics – is the “ownership” of genetic samples from patients.

The potential and richness of this data could hold the key to developing cures, but opportunities are lost if this data is privatised or made inaccessible in some other way.

View the full story here: Ensure open access to genetic data to protect innovation

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend